NHS to offer ‘world’s most expensive’ £1.8m-a-dose drug to cure baby spinal disease

Infants with severe spinal muscular atrophy, which causes muscle weakness and leading to paralysis and breathing problems, will now be able to take the gene therapy drug Zolgensma.